Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
394.28
Dollar change
+0.80
Percentage change
0.20
%
IndexNDX, S&P 500 P/E28.38 EPS (ttm)13.89 Insider Own0.30% Shs Outstand257.70M Perf Week-0.57%
Market Cap101.85B Forward P/E21.70 EPS next Y18.17 Insider Trans-16.40% Shs Float257.54M Perf Month-4.33%
Income3.62B PEG2.22 EPS next Q4.07 Inst Own94.26% Short Float1.54% Perf Quarter-9.37%
Sales9.84B P/S10.35 EPS this Y8.56% Inst Trans1.21% Short Ratio3.22 Perf Half Y7.27%
Book/sh68.22 P/B5.78 EPS next Y9.90% ROA17.56% Short Interest3.98M Perf Year20.04%
Cash/sh43.44 P/C9.08 EPS next 5Y12.80% ROE22.99% 52W Range316.43 - 448.40 Perf YTD-3.10%
Dividend Est.- P/FCF30.52 EPS past 5Y11.42% ROI19.77% 52W High-12.07% Beta0.39
Dividend TTM- Quick Ratio3.78 Sales past 5Y27.16% Gross Margin87.17% 52W Low24.60% ATR (14)7.03
Dividend Ex-Date- Current Ratio3.99 EPS Y/Y TTM8.28% Oper. Margin38.33% RSI (14)33.97 Volatility1.45% 1.63%
Employees5400 Debt/Eq0.05 Sales Y/Y TTM12.47% Profit Margin36.79% Recom1.94 Target Price464.96
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q18.03% Payout0.00% Rel Volume1.07 Prev Close393.48
Sales Surprise0.19% EPS Surprise3.27% Sales Q/Q12.00% EarningsMay 06 AMC Avg Volume1.23M Price394.28
SMA20-3.03% SMA50-4.81% SMA2003.25% Trades Volume1,323,803 Change0.20%
Date Action Analyst Rating Change Price Target Change
Apr-11-24Upgrade Evercore ISI In-line → Outperform $438
Feb-15-24Initiated Wolfe Research Outperform $515
Feb-06-24Downgrade Evercore ISI Outperform → In-line $436 → $438
Feb-02-24Downgrade Bernstein Outperform → Mkt Perform
Jan-31-24Downgrade Robert W. Baird Neutral → Underperform $325
Jan-31-24Downgrade Maxim Group Buy → Hold
Jan-24-24Downgrade Canaccord Genuity Hold → Sell $332 → $379
Dec-14-23Reiterated RBC Capital Mkts Sector Perform $347 → $379
May-30-23Initiated William Blair Outperform $382
May-04-23Resumed Piper Sandler Overweight $385
Apr-20-24 09:45AM
06:48AM
Apr-19-24 05:50PM
11:57AM
04:30AM
08:30AM Loading…
Apr-18-24 08:30AM
08:00AM
07:00AM
Apr-16-24 06:00PM
09:30AM
Apr-15-24 12:00PM
09:15AM
09:04AM
Apr-13-24 08:47AM
05:29AM
10:55AM Loading…
Apr-12-24 10:55AM
Apr-11-24 04:29PM
04:18PM
01:59PM
11:58AM
11:03AM
09:47AM
09:39AM
09:15AM
07:34AM
06:17AM
02:00AM
Apr-10-24 10:34PM
07:05PM
06:00PM
05:47PM Loading…
05:47PM
05:14PM
04:19PM
04:16PM
04:06PM
04:01PM
01:34PM
Apr-09-24 04:05PM
10:07AM
10:00AM
07:37AM
06:35AM
Apr-05-24 09:30AM
Apr-03-24 08:02PM
07:00PM
10:00AM
Apr-02-24 11:26AM
Apr-01-24 05:50PM
11:00AM
09:00AM
08:23AM
08:00AM
04:30AM
Mar-31-24 09:15AM
06:30AM
Mar-30-24 06:50AM
Mar-28-24 04:10PM
09:30AM
Mar-26-24 06:44AM
Mar-25-24 05:50PM
09:10AM
Mar-24-24 10:08AM
Mar-22-24 12:09PM
Mar-21-24 08:00AM
Mar-20-24 01:49PM
Mar-19-24 02:58PM
Mar-18-24 05:50PM
Mar-17-24 09:50AM
09:00AM
08:54AM
Mar-16-24 08:45AM
Mar-14-24 08:15AM
Mar-13-24 07:56AM
Mar-12-24 05:50PM
Mar-09-24 05:52AM
Mar-06-24 02:45PM
11:30AM
Mar-05-24 09:30AM
06:28AM
Mar-04-24 04:09PM
11:02AM
09:18AM
Mar-02-24 09:30AM
Mar-01-24 05:30AM
01:59AM
Feb-29-24 11:26AM
09:00AM
Feb-28-24 11:15PM
03:34PM
07:35AM
Feb-27-24 05:03AM
Feb-26-24 08:50AM
05:52AM
Feb-25-24 07:09AM
Feb-24-24 08:00AM
Feb-23-24 05:00PM
01:42PM
07:10AM
05:50AM
05:43AM
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ambrose KristenSVP & Chief Accounting OfficerApr 02 '24Sale419.00240100,5607,500Apr 03 04:02 PM
Arbuckle Stuart AEVP, COOFeb 26 '24Sale425.705,0342,142,97449,691Feb 27 04:37 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 26 '24Sale425.704,2391,804,54225,813Feb 27 04:24 PM
Sachdev AmitEVP Chief Patient & Ext Af OffFeb 26 '24Sale425.703,0041,278,80355,325Feb 27 04:59 PM
Ambrose KristenSVP & Chief Accounting OfficerFeb 26 '24Sale425.70883375,8937,965Feb 27 04:29 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 26 '24Sale425.70883375,89315,972Feb 27 04:44 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Feb 26 '24Sale425.70354150,69855,804Feb 27 05:02 PM
Arbuckle Stuart AEVP, COOFeb 21 '24Sale421.773,6031,519,63759,439Feb 23 04:12 PM
Sachdev AmitEVP Chief Patient & Ext Af OffFeb 21 '24Sale421.773,1911,345,86860,798Feb 23 04:20 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 21 '24Sale421.773,0021,266,15434,022Feb 23 04:10 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 21 '24Sale421.771,201506,54618,509Feb 23 04:16 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Feb 21 '24Sale421.77360151,83759,467Feb 23 04:28 PM
Arbuckle Stuart AEVP, COOFeb 20 '24Sale420.794,8042,021,47563,042Feb 21 04:19 PM
Sachdev AmitEVP Chief Patient & Ext Af OffFeb 20 '24Sale420.794,2541,790,04163,989Feb 21 04:38 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 20 '24Sale420.794,0021,684,00237,024Feb 21 04:13 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 20 '24Sale420.79801337,05319,710Feb 21 04:23 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Feb 20 '24Sale420.79480201,97959,827Feb 21 04:43 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 15 '24Sale419.164,6551,951,19017,896Feb 16 04:07 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 14 '24Sale419.044,3561,825,33822,551Feb 16 04:07 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 13 '24Sale419.13737308,89926,907Feb 14 04:04 PM
Arbuckle Stuart AEVP, COOFeb 12 '24Sale420.244,2951,804,93175,718Feb 13 04:51 PM
Sachdev AmitEVP Chief Patient & Ext Af OffFeb 12 '24Sale420.243,2221,354,01374,364Feb 13 05:15 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 12 '24Sale420.243,1451,321,65547,588Feb 13 04:46 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 12 '24Sale419.512,6561,114,20527,644Feb 14 04:04 PM
Biller JonathanEVP and Chief Legal OfficerFeb 12 '24Sale418.771,738727,82218,280Feb 13 04:56 PM
Ambrose KristenSVP & Chief Accounting OfficerFeb 12 '24Sale420.241,374577,4109,676Feb 13 04:48 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 12 '24Sale420.24913383,67923,137Feb 13 04:54 PM
LEIDEN JEFFREY MExecutive ChairmanJan 08 '24Sale419.076,6482,785,9772,423Jan 10 04:06 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerJan 02 '24Sale405.003,0001,215,00043,693Jan 04 04:17 PM
Kewalramani ReshmaCEO & PresidentDec 15 '23Option Exercise181.8317,1353,115,593125,846Dec 19 04:15 PM
Kewalramani ReshmaCEO & PresidentDec 15 '23Sale407.0017,1356,973,945108,711Dec 19 04:15 PM
Arbuckle Stuart AEVP, COODec 13 '23Option Exercise187.538,6031,613,32165,159Dec 15 04:20 PM
LEIDEN JEFFREY MExecutive ChairmanDec 13 '23Sale399.4213,3545,333,7999,071Dec 15 04:33 PM
Arbuckle Stuart AEVP, COODec 13 '23Sale399.008,6033,432,59756,556Dec 15 04:20 PM
Kewalramani ReshmaCEO & PresidentDec 13 '23Sale397.005,0982,023,906108,711Dec 15 04:23 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerNov 20 '23Sale349.883,0001,049,64046,693Nov 21 04:07 PM
Sachdev AmitEVP Chief Patient & Ext Af OffNov 15 '23Sale369.923512,94758,814Nov 17 04:16 PM
ALTSHULER DAVIDEVP, Global Research and CSONov 15 '23Sale369.92197,02832,038Nov 17 04:11 PM
Bozic CarmenEVP and CMONov 14 '23Sale380.825,6502,151,63329,302Nov 16 04:15 PM
Kewalramani ReshmaCEO & PresidentNov 13 '23Sale377.005,0971,921,569113,809Nov 15 04:16 PM
SACHS BRUCE IDirectorNov 06 '23Option Exercise127.5411,2501,434,82551,250Nov 08 04:11 PM
SACHS BRUCE IDirectorNov 06 '23Sale385.0011,2504,331,25040,000Nov 08 04:11 PM
Bozic CarmenEVP and CMOOct 31 '23Sale355.925,6512,011,30434,952Nov 02 04:07 PM
Bozic CarmenEVP and CMOOct 17 '23Sale373.255,6512,109,23640,603Oct 19 04:18 PM
Bhatia Sangeeta N.DirectorOct 17 '23Sale375.0024391,1253,901Oct 19 04:13 PM
LEIDEN JEFFREY MExecutive ChairmanOct 16 '23Sale374.0012,9624,847,78822,425Oct 18 04:17 PM
Bhatia Sangeeta N.DirectorOct 06 '23Sale360.0024287,1204,144Oct 11 04:14 PM
Bozic CarmenEVP and CMOOct 03 '23Sale345.285,6511,951,17746,254Oct 05 04:30 PM
Biller JonathanEVP and Chief Legal OfficerOct 02 '23Sale346.76610211,52410,569Oct 03 04:07 PM
Bozic CarmenEVP and CMOSep 19 '23Sale351.005,6511,983,50151,905Sep 21 04:15 PM
Bozic CarmenEVP and CMOSep 05 '23Sale352.665,6511,992,88257,556Sep 07 04:29 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Aug 23 '23Sale355.002,500887,50048,637Aug 25 04:14 PM
Kearney Terrence CDirectorAug 10 '23Option Exercise127.5410,0001,275,40016,536Aug 14 04:09 PM
Sachdev AmitEVP, Chief Patient OfficerAug 10 '23Sale350.0010,0313,510,85058,814Aug 14 04:05 PM
Kearney Terrence CDirectorAug 10 '23Sale350.0010,0003,500,0006,536Aug 14 04:09 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Aug 10 '23Sale345.795,7501,988,29351,137Aug 14 04:08 PM
Bhatia Sangeeta N.DirectorAug 09 '23Sale345.5124283,6134,386Aug 11 04:05 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 09 '23Sale345.516321,76732,038Aug 11 04:05 PM
SACHS BRUCE IDirectorJul 17 '23Option Exercise127.5411,2501,434,82551,250Jul 18 04:17 PM
SACHS BRUCE IDirectorJul 17 '23Sale356.7511,2504,013,45940,000Jul 18 04:17 PM
Kewalramani ReshmaCEO & PresidentJul 17 '23Sale355.007,8282,778,940118,906Jul 18 04:13 PM
Arbuckle Stuart AEVP, COOJun 15 '23Option Exercise187.538,6031,613,32165,159Jun 20 04:07 PM
Arbuckle Stuart AEVP, COOJun 15 '23Sale349.008,6033,002,44756,556Jun 20 04:07 PM
Ambrose KristenSVP & Chief Accounting OfficerMay 30 '23Sale329.8228995,3186,838Jun 01 04:12 PM
Arbuckle Stuart AEVP, COOMay 30 '23Sale329.828227,04556,556Jun 01 04:16 PM
Sanna BastianoEVP, Cell & Genetic TherapiesMay 08 '23Sale350.002,850997,50032,038May 09 04:15 PM
LEIDEN JEFFREY MExecutive ChairmanMay 08 '23Sale349.001,125392,62535,387May 09 04:10 PM
LEIDEN JEFFREY MExecutive ChairmanMay 05 '23Sale349.56879307,26236,512May 09 04:10 PM
Sanna BastianoEVP, Cell & Genetic TherapiesMay 05 '23Sale350.03422147,71334,888May 09 04:15 PM
LEIDEN JEFFREY MExecutive ChairmanMay 03 '23Sale350.114,5081,578,30137,391May 04 04:50 PM
Sanna BastianoEVP, Cell & Genetic TherapiesMay 03 '23Sale350.742,781975,41835,310May 04 04:51 PM
LEIDEN JEFFREY MExecutive ChairmanMay 02 '23Sale349.896,4502,256,76141,899May 04 04:50 PM
Sanna BastianoEVP, Cell & Genetic TherapiesMay 02 '23Sale350.661,622568,76838,091May 04 04:51 PM
Bhatia Sangeeta N.DirectorMay 02 '23Sale348.28580202,0044,628May 03 04:44 PM
Kewalramani ReshmaCEO & PresidentApr 27 '23Sale339.083,3171,124,726126,652May 01 04:26 PM